A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...

The EMA's main advisory committee has backed approval of Novo Nordisk's oral GLP-1 agonist Rybelsus ... treat various cancer indications and rheumatoid arthritis.

Several local companies are developing technologies that they hope could replace a painful poke with something that feels more like having Velcro against your skin for a few minutes.

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

In honor of American Heart Month, Healio Dermatology interviewed experts and explored the connection between skin disease and heart health.The discovery of this relationship can be traced back to ...

Gut health is about how well your body digests food, absorbs nutrients, and maintains a balance of good and bad bacteria.

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

Glucagon-like peptide-1 (GLP-1) is a well-known medication used by physicians to treat Type 2 diabetes. GLP-1 has also become ...